Key Considerations For A Direct-to-Patient Clinical Trial
Source: 4G Clinical
This webinar we explore important considerations for developing a Direct-to-Patient strategy and the RTSM features needed to support its execution.
Topics to be discussed include:
- The impact of COVID-19 on clinical trials, including perspectives from patients, sites and sponsors
- Whether or not DtP makes sense for you trial, and if so, what model?
- The RTSM as a solution when implementing a robust DtP strategy
- Key considerations for a DtP strategy, including an actionable checklist to discuss with your team
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Tech Leader? Subscribe today.
Subscribe to Clinical Tech Leader
X
Subscribe to Clinical Tech Leader
This website uses cookies to ensure you get the best experience on our website. Learn more